Cargando…
A-agents, misleadingly known as “Novichoks”: a narrative review
“Novichok” refers to a new group of nerve agents called the A-series agents. Their existence came to light in 2018 after incidents in the UK and again in 2020 in Russia. They are unique organophosphorus-based compounds developed during the Cold War in a program called Foliant in the USSR. This revie...
Autores principales: | Opravil, Jakub, Pejchal, Jaroslav, Finger, Vladimir, Korabecny, Jan, Rozsypal, Tomas, Hrabinova, Martina, Muckova, Lubica, Hepnarova, Vendula, Konecny, Jan, Soukup, Ondrej, Jun, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475003/ https://www.ncbi.nlm.nih.gov/pubmed/37612377 http://dx.doi.org/10.1007/s00204-023-03571-8 |
Ejemplares similares
-
Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors
por: Svobodova, Barbora, et al.
Publicado: (2019) -
Structure-Guided Design of N-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer’s Disease
por: Svobodova, Barbora, et al.
Publicado: (2023) -
Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation
por: Spilovska, Katarina, et al.
Publicado: (2017) -
Development of 2-Methoxyhuprine as Novel Lead for Alzheimer’s Disease Therapy
por: Mezeiova, Eva, et al.
Publicado: (2017) -
Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods
por: Janockova, Jana, et al.
Publicado: (2018)